2012
DOI: 10.1007/s00044-012-0053-7
|View full text |Cite
|
Sign up to set email alerts
|

Atom-based 3D QSAR studies on novel N-β-d-xylosylindole derivatives as SGLT2 inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Homology modeling, molecular docking were administered on 54 C-aryl glycosides analogues, providing fundamental structural insights into the active site and key interactions involved in the binding of inhibitors to hSGLT2 [8] . 3D pharmacophore models and atom-based 3D-QSAR models have inhibitors [9] . Optimization of Gaussian Kernel Function in Support Vector Machine…”
Section: Introductionmentioning
confidence: 99%
“…Homology modeling, molecular docking were administered on 54 C-aryl glycosides analogues, providing fundamental structural insights into the active site and key interactions involved in the binding of inhibitors to hSGLT2 [8] . 3D pharmacophore models and atom-based 3D-QSAR models have inhibitors [9] . Optimization of Gaussian Kernel Function in Support Vector Machine…”
Section: Introductionmentioning
confidence: 99%
“…Most of the currently reported SGLT2 inhibitors are glucoside derivatives and are based on phlorizin (i.e., a naturallyoccurring O-aryl glycoside) [1]. Some quantitative structure-activity relationship (QSAR) models have been developed for glycoside molecules [2][3][4][5]. However, some SGLT2 inhibitors (dapagliflozin, canagliflozin, and empagliflozin are glucosides derived from the prototype phlorizin [6,7]) in clinical development inhibit only 30-50% of glucose reabsorption [8].…”
Section: Introductionmentioning
confidence: 99%